Medicare Enrolled
Dr. Omar Hamoui, M.D.
Urology Physician · Brooksville, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hamoui from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hamoui? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hamoui
Dr. Omar Hamoui is an urology physician in Brooksville, FL, with 18 years in practice. Based on federal Medicare data, Dr. Hamoui performed 8,382 Medicare services across 5,146 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hamoui received a total of $10,020 from 48 pharmaceutical and/or device companies across 264 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hamoui is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 14% volume in FL$ $10,020 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,382
Medicare services
Top 14% in FL for urology physician
5,146
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~466 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,894 | $98 | $250 |
| Automated urinalysis | 939 | $2 | $8 |
| Leuprolide injectable, camcevi, 1 mg | 924 | $67 | $143 |
| Bladder ultrasound after voiding | 800 | $8 | $40 |
| Injection, mitomycin, 5 mg | 376 | $42 | $200 |
| Diagnostic exam of bladder and urethra using an endoscope | 303 | $183 | $430 |
| Blood draw (venipuncture) | 266 | $8 | $15 |
| Hospital follow-up visit, high complexity | 253 | $94 | $192 |
| Testosterone (hormone) level, total | 248 | $25 | $90 |
| Initial hospital admission, high complexity | 247 | $137 | $322 |
| PSA test (prostate cancer screening) | 246 | $18 | $68 |
| New patient office visit (45-59 min) | 166 | $127 | $226 |
| Complete ultrasound scan behind abdominal cavity | 143 | $81 | $264 |
| Limited ultrasound scan of pelvis | 133 | $37 | $200 |
| Electronic assessment of bladder emptying | 120 | $6 | $140 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 120 | $25 | $410 |
| New patient office visit, complex (60-74 min) | 104 | $167 | $351 |
| Ultrasound scan of pelvic region through rectum | 94 | $74 | $456 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 86 | $40 | $487 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 81 | $271 | $501 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 74 | $328 | $982 |
| Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope | 66 | $574 | $1,500 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 56 | $247 | $500 |
| Placement of hormone pellet under skin | 51 | $74 | $200 |
| Unclassified drugs | 51 | $723 | $1,500 |
| Dilation of urethra using an endoscope | 50 | $253 | $590 |
| Instillation of anti-cancer drug into bladder | 47 | $67 | $370 |
| Biopsy of bladder using an endoscope | 44 | $111 | $900 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 39 | $292 | $507 |
| Insertion of device into abdomen with pressure and urine flow rate study | 39 | $147 | $400 |
| Waterjet destruction of prostrate accessed through the urethra | 31 | $550 | $2,371 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 31 | $26 | $75 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 29 | $573 | $1,780 |
| Insertion of stent in ureter using an endoscope | 25 | $74 | $686 |
| Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope | 24 | $214 | $615 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 24 | $154 | $691 |
| Hospital follow-up visit, moderate complexity | 24 | $63 | $149 |
| Office visit, established patient, complex (40-54 min) | 21 | $133 | $300 |
| Destruction and/or removal of large growth of bladder using an endoscope | 18 | $249 | $1,080 |
| Insertion of sacral nerve neurostimulator electrode array | 16 | $846 | $2,500 |
| Insertion of needle or tube into prostate for radiation therapy | 15 | $615 | $1,620 |
| Office visit, established patient (20-29 min) | 15 | $70 | $140 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 14 | $130 | $343 |
| Biopsy of prostate gland | 12 | $188 | $450 |
| Ultrasonic guidance for needle placement | 12 | $45 | $400 |
| Injection procedure to cause erection | 11 | $71 | $190 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
20.0% medium
78.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,020
Total received (2018-2024)
Avg $1,431/year across 7 years
Top 21% in FL for urology physician
48
Companies
264
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,996 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,697
2023$3,082
2022$1,843
2021$1,468
2020$279
2019$437
2018$213
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$2,451
Medtronic, Inc.
$1,668
PROCEPT BioRobotics Corporation
$1,188
COLOPLAST CORP
$606
Boston Scientific Corporation
$433
Axonics, Inc.
$374
Coloplast Corp
$339
UROVANT SCIENCES INC
$310
Sumitomo Pharma America, Inc.
$305
Astellas Pharma US Inc
$303
Intuitive Surgical, Inc.
$239
United Medical Systems (DE), Inc.
$227
Ethicon US, LLC
$167
Acerus Pharmaceuticals Corporation
$137
Telix Pharmaceuticals
$112
PFIZER INC.
$107
TOLMAR Pharmaceuticals, Inc.
$85
180 Medical, Inc.
$85
NeoTract Inc.
$67
Laborie Medical Technologies Corp.
$64
Verity Pharmaceuticals Inc.
$60
Rochester Medical Corporation
$50
ROCHESTER MEDICAL CORPORATION
$44
Janssen Biotech, Inc.
$40
Clarus Therapeutics Inc.
$37
Accord Healthcare, Inc.
$36
Metuchen Pharmaceuticals
$31
Merck Sharp & Dohme LLC
$31
AbbVie, Inc.
$31
E.R. Squibb & Sons, L.L.C.
$30
Avadel Specialty Pharmaceuticals, LLC
$30
DENTSPLY IH Inc.
$29
Myovant Sciences Inc.
$27
Antares Pharma, Inc.
$26
ACCORD HEALTHCARE, INC.
$25
Pacira Pharmaceuticals Incorporated
$24
Merck Sharp & Dohme Corporation
$22
Endo Pharmaceuticals Inc.
$22
Progenics Pharmaceuticals, Inc.
$21
Biogen, Inc.
$19
Tolmar, Inc.
$18
UroGen Pharma, Inc.
$17
Blue Earth Diagnostics Limited
$17
UROGEN PHARMA, INC.
$14
Medtronic USA, Inc.
$14
Caldera Medical, Inc
$13
KARL STORZ Endoscopy-America
$13
BOSTON SCIENTIFIC CORPORATION
$12
Top 3 companies account for 53.0% of total payments
Associated products mentioned in payments ›
16 FR. FLEXIBLE VIDEO CYSTOSCOPE · AMS 700 CXR RTE Kit · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Altis · Androgel · Axonics · Axonics r-SNM System · Axumin · Bulkamid · CAMCEVI · Certus 140 · Da Vinci Surgical System · Desara · ELIGARD · ELIQUIS · ERLEADA · Echelon; Endopath · Erleada · Exparel · GEMTESA · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENTLECATH · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LoFric · Lupron · Myrbetriq · Natesto · Noctiva · ORGOVYX · PYLARIFY · REZUM · SPEEDICATH · SPINRAZA · SUTENT · Saffron · SpaceOAR VUE System - 10mL · Stendra · TOVIAZ · Titan · Trelstar · UROLIFT · UroLift · UroLift 2 System · UroLift System · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $120 per 100 Medicare services performed
Geographic Context
Urology Physicians within 10 mi
20
Per 100K population
9.9
County median income
$63,193
Nearest hospital
HCA FLORIDA OAK HILL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hamoui is a clinical cardiology specialist, with above-average Medicare volume (top 14% in FL), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hamoui experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hamoui performed 1,894 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hamoui receive payments from pharmaceutical companies?
Yes. Dr. Hamoui received a total of $10,020 from 48 companies across 264 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hamoui's costs compare to other urology physicians in Brooksville?
Dr. Hamoui's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hamoui) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Brooksville
Browse urology physicians in Brooksville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology